HB 2164 Hawaii House · 2026 Regular Session

RELATING TO WORKERS' COMPENSATION.

HB 2164 defines "compounded prescription drugs" specifically for workers' compensation claims. This bill directly affects injured workers seeking medical coverage and insurers processing those claims. It establishes a clear legal definition to determine which custom-mixed medications qualify for coverage under workers' compensation law. This clarification aims to reduce disputes over medication eligibility in injury claims. The bill does not change existing coverage rules but provides a precise standard for applying them.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2026

Committee Review

Mar 2026

House Passage

Mar 2026

Senate Passage

Governor

Introduced Jan 26, 2026 Last action Mar 17, 2026

Maddy AI version diff · 1 comparison

What changed between versions

HB2164 → HB2164_HD1 · 3 edits

MINOR

The bill was updated from its original House Draft version to the House Draft 1 version, primarily involving administrative metadata updates and a significant change to the effective date. The most critical substantive change is the extension of the bill's effective date from July 1, 2026, to July 1, 3000, which delays when the new pharmacy compounding rules will become active. Additionally, the legal definition of a 'compounded prescription drug' was slightly refined to align more closely with federal standards, and the bill's title was updated to reflect its new draft number.

Scope change

The bill's scope regarding workers' compensation and pharmacy compounding remains substantively the same, but the timeline for implementation has been drastically altered.

TIMELINE

The effective date of the Act was changed from July 1, 2026, to July 1, 3000, meaning the new regulations will not take effect for over a century.

DEFINITION

The definition of 'compounded prescription drug' was updated to reference a specific federal code section (353a) and adjusted the phrasing to ensure alignment with federal standards.

TECHNICAL

Administrative metadata, including the bill number, author names, and internal tracking codes, were updated to reflect the transition to the House Draft 1 version.

Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 17, 2026

Committee

Re-Referred to LBT/HHS, CPN/JDC.

upper

Mar 12, 2026

Committee

Referred to LBT/HHS, JDC.

upper

Mar 12, 2026

Introduced

Received from House (Hse. Com. No. 371).

upper

Mar 10, 2026

Lower · Passed

Passed Third Reading with none voting aye with reservations; Representative(s) Pierick voting no (1) and none excused (0). Transmitted to Senate.

lower

Mar 4, 2026

Lower · Passed

The committee on CPC recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 10 Ayes: Representative(s) Matayoshi, Grandinetti, Chun, Ilagan, Ichiyama, Iwamoto, Kong, Lowen, Marten, Tam; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Pierick.

lower

Feb 20, 2026

Committee

Reported from LAB (Stand. Com. Rep. No. 634-26) as amended in HD 1, recommending passage on Second Reading and referral to CPC.

lower

Feb 17, 2026

Lower · Passed

The committee on LAB recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Sayama, Lee, M., Garrett, Kapela, Kong, Reyes Oda; Ayes with reservations: none; Noes: none; and Excused: none.

lower

Jan 30, 2026

Committee

Referred to LAB, CPC, referral sheet 5

lower

Jan 28, 2026

Introduced

Introduced and Pass First Reading.

lower

Jan 26, 2026

Introduced

Pending introduction.

lower

10 primary · 0 co-sponsors